Estabrook Capital Management - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 299 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.2%.

Quarter-by-quarter ownership
Estabrook Capital Management ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$488
-99.9%
140.0%0.00%
Q3 2022$783,000
+8.0%
140.0%0.00%
Q2 2022$725,000
-28.7%
140.0%0.00%
Q1 2022$1,017,000
-38.5%
140.0%0.00%
Q4 2021$1,655,000
-11.9%
140.0%0.00%
Q3 2021$1,878,000
-17.2%
140.0%0.00%
Q2 2021$2,267,000
+101.7%
140.0%0.00%
Q1 2021$1,124,000
+47.5%
140.0%0.00%
Q4 2020$762,000
+174.1%
140.0%0.00%
Q3 2020$278,000
-5.4%
140.0%0.00%
Q2 2020$294,000
+71.9%
140.0%0.00%
Q1 2020$171,000
-16.6%
140.0%0.00%
Q4 2019$205,000140.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders